{
  "schema_version": "interaction_classes_v1",
  "updated_at": "2026-01-21",
  "drug_classes": [
    {
      "slug": "anticoagulants-antiplatelets",
      "title": "Anticoagulants / antiplatelets",
      "aka": [
        "blood thinners",
        "anticoagulants",
        "antiplatelets"
      ],
      "notes": "Bleeding/clotting risk context.",
      "label": "Anticoagulants / antiplatelets",
      "definition": "Context bucket for peptides that may plausibly influence bleeding/clotting balance, platelet function, or vascular repair in a way that could matter alongside anticoagulant or antiplatelet medications.",
      "strictness": "context",
      "tagging_rules": [
        "Use when bleeding/clotting pathways are meaningfully implicated.",
        "Do not imply a proven clinical interaction; this is a cautionary context flag."
      ]
    },
    {
      "slug": "antihypertensives",
      "title": "Antihypertensives / BP-lowering agents",
      "aka": [
        "bp meds",
        "blood pressure meds",
        "ace inhibitors",
        "arbs",
        "beta blockers"
      ],
      "notes": "Use this class for peptides that can materially shift blood pressure via vascular tone or fluid balance. This is interaction-relevance for people on BP-lowering drugs, not a claim the peptide is an antihypertensive medication.",
      "label": "Antihypertensives",
      "definition": "Context bucket for peptides that may influence blood pressure or vascular resistance in a way that could matter alongside antihypertensive medications.",
      "strictness": "context",
      "tagging_rules": [
        "Use when BP modulation is plausible and non-trivial."
      ]
    },
    {
      "slug": "diabetes-glucose-lowering",
      "title": "Glucose-lowering agents",
      "aka": [
        "insulin",
        "metformin",
        "sulfonylureas",
        "sglt2",
        "glp-1",
        "glp1"
      ],
      "notes": "Hypoglycemia risk context; appetite/gastric effects context.",
      "label": "Diabetes / glucose lowering",
      "definition": "Context bucket for peptides that influence glucose regulation, insulin sensitivity, or glycemic control in a way that could matter alongside diabetes therapies.",
      "strictness": "context",
      "tagging_rules": [
        "Use when glycemic effects are relevant, especially outside GLP-1/incretin-specific mechanisms."
      ]
    },
    {
      "slug": "immunosuppressants",
      "title": "Immunosuppressants / immune-modulating drugs",
      "aka": [
        "biologics",
        "immunosuppressants"
      ],
      "notes": "Immune modulation/infection risk context.",
      "label": "Immunosuppressants",
      "definition": "Context bucket for peptides that meaningfully modulate immune signaling or immune cell activity in a way that could matter alongside immunosuppressive therapies.",
      "strictness": "context",
      "tagging_rules": [
        "Use when immune modulation is central (not vague “immune support”)."
      ]
    },
    {
      "slug": "corticosteroids",
      "title": "Corticosteroids",
      "aka": [
        "prednisone",
        "steroids"
      ],
      "notes": "Immune/metabolic and wound-healing context.",
      "label": "Corticosteroids",
      "definition": "Context bucket for peptides that modulate inflammatory or immune pathways that could overlap with, or be affected by, corticosteroid use.",
      "strictness": "context",
      "tagging_rules": [
        "Use when immune/inflammatory modulation is a core feature."
      ]
    },
    {
      "slug": "antidiabetics-insulin-glp1",
      "title": "Antidiabetics (Insulin/GLP-1 and related)",
      "aka": [
        "diabetes-glucose-lowering",
        "diabetes meds",
        "glucose lowering",
        "blood sugar meds",
        "antidiabetics",
        "GLP-1",
        "GLP1",
        "incretin",
        "insulin"
      ],
      "notes": "Routing/labeling class for diabetes medications (incretin/GLP-1 class, insulin and related). Educational only.",
      "label": "Antidiabetics (insulin/GLP-1 axis)",
      "definition": "Bucket for peptides primarily acting on insulin secretion, incretin/GLP-1 signaling, or closely related glucose-control mechanisms.",
      "strictness": "normal",
      "tagging_rules": [
        "Use when insulin/GLP-1/incretin mechanisms are central."
      ]
    },
    {
      "slug": "nsaids",
      "title": "NSAIDs (ibuprofen/naproxen and related)",
      "aka": [
        "ibuprofen",
        "naproxen",
        "aspirin",
        "celecoxib",
        "diclofenac",
        "indomethacin",
        "meloxicam",
        "toradol",
        "ketorolac",
        "nsaid"
      ],
      "notes": "Routing/labeling class for nonsteroidal anti-inflammatory drugs. Educational only.",
      "label": "NSAIDs",
      "definition": "Context bucket for peptides whose primary effects overlap with inflammation signaling, tissue repair, or pathways commonly affected by NSAIDs.",
      "strictness": "context",
      "tagging_rules": [
        "Use when inflammation modulation or tissue repair is central to the peptide’s effects.",
        "Avoid if overlap is incidental or purely speculative."
      ]
    },
    {
      "slug": "ssri-snri-serotonergic",
      "title": "SSRIs/SNRIs and other serotonergic agents",
      "aka": [
        "ssri",
        "snri",
        "serotonergic",
        "serotonin meds",
        "serotonin reuptake inhibitor",
        "fluoxetine",
        "sertraline",
        "escitalopram",
        "citalopram",
        "paroxetine",
        "venlafaxine",
        "duloxetine",
        "serotonin syndrome"
      ],
      "notes": "Routing/labeling class for serotonergic antidepressants and agents. Educational only.",
      "label": "SSRIs/SNRIs (serotonergic)",
      "definition": "Context bucket for peptides that influence serotonergic signaling or CNS pathways in a way that could matter alongside SSRIs, SNRIs, or other serotonergic agents.",
      "strictness": "context",
      "tagging_rules": [
        "Use when serotonergic overlap is plausible and relevant to the peptide’s effects."
      ]
    },
    {
      "slug": "anti-infectives-antimicrobials",
      "title": "Anti-infectives / antimicrobials (antibiotics, antivirals, antifungals)",
      "aka": [
        "antibiotics",
        "antibiotic",
        "antimicrobials",
        "antimicrobial",
        "antibacterial",
        "antiviral",
        "antifungal",
        "infection meds",
        "anti-infectives"
      ],
      "notes": "Routing/labeling class for anti-infective medications. Educational only.",
      "label": "Anti-infectives / antimicrobials",
      "definition": "Narrow bucket for peptides with direct, widely accepted antimicrobial/anti-infective activity against pathogens (not just indirect immune modulation).",
      "strictness": "narrow",
      "tagging_rules": [
        "Use only when direct pathogen-targeting activity is central and broadly supported.",
        "Do not use for indirect immune effects or general immune modulation."
      ]
    },
    {
      "slug": "immune-modulation-infection-risk",
      "title": "Immune modulation / infection risk context",
      "aka": [
        "immune modulation",
        "infection risk",
        "immune system",
        "opportunistic infection",
        "immunomodulator context"
      ],
      "notes": "Educational grouping for peptides that frequently appear in immune/infection discussions. Not a medication class.",
      "label": "Immune modulation / infection risk",
      "definition": "Context bucket for peptides that alter immune signaling or inflammatory balance in a way that could affect infection susceptibility or immune surveillance. This does not imply antimicrobial action.",
      "strictness": "context",
      "tagging_rules": [
        "Use for meaningful immune modulation where infection risk is a reasonable consideration.",
        "Do not use to imply direct antimicrobial effects."
      ]
    },
    {
      "slug": "cardiovascular-physiology-context",
      "title": "Cardiovascular physiology / vasoactive peptide context",
      "aka": [
        "cardiovascular physiology",
        "vasoactive peptides",
        "blood pressure regulation",
        "vascular tone",
        "hemodynamics",
        "cardiac peptides"
      ],
      "notes": "Educational context grouping for endogenous or peptide-like agents involved in cardiovascular regulation (BP, volume, vascular tone). Not a medication class.",
      "label": "Cardiovascular physiology (context)",
      "definition": "Bucket for peptides meaningfully involved in vascular tone, blood pressure regulation, cardiac signaling, or cardiovascular physiology.",
      "strictness": "normal",
      "tagging_rules": [
        "Use when BP/vascular tone/cardiac signaling is meaningfully involved."
      ]
    },
    {
      "slug": "endocrine-axis-modulation-context",
      "title": "Endocrine axis modulation (HPT/HPA/HPG/GH context)",
      "aka": [
        "endocrine axis",
        "pituitary",
        "hypothalamus",
        "hormone axis",
        "hpG axis",
        "hpA axis",
        "hpT axis",
        "gh axis",
        "gonadotropin",
        "gnrh",
        "lh",
        "fsh",
        "testosterone",
        "estrogen",
        "growth hormone",
        "igf-1",
        "thyroid axis",
        "cortisol axis"
      ],
      "notes": "Educational grouping for peptides/hormones that directly influence endocrine axes. Not a medication class.",
      "label": "Endocrine axis modulation (context)",
      "definition": "Bucket for peptides that influence hormonal signaling and endocrine feedback loops (e.g., HPG/HPA/GH axes) in a way that can affect interpretation or interactions with hormone-based therapies.",
      "strictness": "normal",
      "tagging_rules": [
        "Use when axis-level hormonal signaling or feedback is involved."
      ]
    },
    {
      "slug": "neuropeptide-cns-context",
      "title": "Neuropeptides / CNS signaling (context)",
      "aka": [
        "cns",
        "central nervous system",
        "neuropeptide",
        "neuromodulator",
        "orexin",
        "hypocretin",
        "substance p",
        "tachykinin",
        "neuropeptide y",
        "npy",
        "oxytocin",
        "vasopressin",
        "melanocortin",
        "alpha msh",
        "msh",
        "endorphin",
        "enkephalin",
        "somatostatin",
        "crh",
        "trh",
        "gnrh"
      ],
      "notes": "Educational grouping for endogenous peptides with prominent CNS signaling roles. Not a medication class.",
      "label": "Neuropeptide (CNS context)",
      "definition": "Bucket for peptides acting primarily within neuropeptide/CNS signaling networks (e.g., mood, cognition, arousal, autonomic signaling).",
      "strictness": "normal",
      "tagging_rules": [
        "Use when CNS/neuropeptide signaling is a primary mechanism/effect domain."
      ]
    }
  ],
  "supplement_classes": [
    {
      "slug": "cns-stimulants",
      "title": "CNS stimulants (supplements)",
      "aka": [
        "caffeine",
        "preworkout",
        "stimulant supplements"
      ],
      "notes": "HR/BP and anxiety/insomnia context.",
      "label": "CNS stimulants",
      "definition": "Context bucket for substances used for stimulation/alertness that can meaningfully affect arousal, sleep, anxiety, heart rate, or blood pressure (e.g., stimulant-style nootropics). This bucket flags possible additive physiologic effects, not a proven drug interaction.",
      "strictness": "context",
      "tagging_rules": [
        "Use when stimulation/arousal is a primary intended effect and could plausibly stack with other stimulants.",
        "Avoid for mild or indirect effects unless stimulation is a core user-reported purpose."
      ]
    },
    {
      "slug": "serotonergic-supplements",
      "title": "Serotonergic supplements",
      "aka": [
        "st johns wort",
        "5-htp",
        "tryptophan"
      ],
      "notes": "Serotonin syndrome context.",
      "label": "Serotonergic supplements",
      "definition": "Context bucket for supplements discussed as increasing serotonin signaling or serotonin precursor availability. This flags potential serotonergic stacking alongside SSRIs/SNRIs/MAOIs or other serotonergic agents; it does not assert that serotonin syndrome risk is established.",
      "strictness": "context",
      "tagging_rules": [
        "Use for supplements whose primary mechanism/marketing is serotonergic or serotonin-precursor based.",
        "Avoid if serotonergic linkage is remote, disputed, or not central to the supplement’s use."
      ]
    },
    {
      "slug": "anticoagulant-herbs",
      "title": "Anticoagulant / antiplatelet herbs",
      "aka": [
        "fish oil",
        "ginkgo",
        "garlic",
        "turmeric"
      ],
      "notes": "Bleeding risk context.",
      "label": "Anticoagulant herbs / supplements",
      "definition": "Context bucket for supplements commonly discussed as affecting coagulation, platelet activity, or bleeding tendency (e.g., ‘blood-thinning’ supplements). This is a cautionary context label, not proof of clinically meaningful interaction.",
      "strictness": "context",
      "tagging_rules": [
        "Use when a supplement is widely recognized in consumer/clinical discussion as influencing bleeding/clotting risk.",
        "Do not use to imply equivalence to prescription anticoagulants/antiplatelets.",
        "Avoid unless the supplement’s bleeding/clotting relevance is central and repeatably cited across credible references."
      ]
    },
    {
      "slug": "glucose-lowering-supplements",
      "title": "Glucose-lowering supplements",
      "aka": [
        "berberine",
        "alpha lipoic acid",
        "chromium"
      ],
      "notes": "Hypoglycemia risk context.",
      "label": "Glucose-lowering supplements",
      "definition": "Context bucket for supplements commonly used to support glycemic control (fasting glucose, post-meal glucose, insulin sensitivity). This signals potential additive effects with glucose-lowering medications, not a guarantee of clinically significant interaction.",
      "strictness": "context",
      "tagging_rules": [
        "Use when a supplement’s primary intent is glycemic control or insulin sensitivity support.",
        "Avoid if glucose effects are speculative, incidental, or weakly supported."
      ]
    }
  ]
}
